Effect of cholesterol and amyloid-β peptide on structure and function of mixed-lipid films and pulmonary surfactant BLES: An atomic force microscopy study

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 6, 2010, Pages 808-814

  Hane, Francis ^a   Drolle, Elizabeth ^a   Leonenko, Zoya ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Amyloid ; Atomic force microscopy; Cholesterol; Lipid; Nanoscale structure; Protein; Pulmonary surfactant; Surfactant dysfunction

Indexed keywords

ADVERSE EFFECT; ATOMIC FORCE; LIPID FILMS; MAMMALIAN LUNGS; MOLECULAR FILMS; MULTILAYER FORMATION; MULTILAYER STRUCTURES; NANOSCALE STRUCTURE; POSITIVE EFFECTS; PULMONARY SURFACTANTS; SMALL CONCENTRATION; SURFACE ACTIVITIES; SURFACE-ACTIVE PROPERTY; SURFACTANT DYSFUNCTION; SURFACTANT FORMULATION; WORK OF BREATHINGS;

ATOMIC FORCE MICROSCOPY; CHOLESTEROL; GLYCOPROTEINS; MAMMALS; MULTILAYERS; NANOSTRUCTURED MATERIALS; PEPTIDES; PHOSPHOLIPIDS; SURFACE TENSION;

SURFACE ACTIVE AGENTS;

1,2 DIOLEOYLGLYCERO 3 PHOSPHOGLYCEROL; AMYLOID BETA PROTEIN[1-40]; BLES; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPID; LUNG SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; COMPRESSION; FILM; LIPID MEMBRANE; LUNG ALVEOLUS; NANOTECHNOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RACEMIC MIXTURE; SURFACE PROPERTY;

AMYLOID BETA-PEPTIDES; CHOLESTEROL; MICROSCOPY, ATOMIC FORCE; PULMONARY SURFACTANTS;

MAMMALIA;

EID: 78649878435     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.05.001     Document Type: Article

References (40)

1. Scarpelli E.M., Clutario B.C., Taylor F.A. Preliminary identification of the lung surfactant system. J Appl Physiol 1967, 23:880-886.
2. Holm B., Enhorning G., Notter R.H. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988, 49:49-55.
3. Floros J., Phelps D.S., Pison U., Spragg R. Pulmonary surfactant-update on function, molecular biology and clinical implications. Respir Med Rev 2005, 1:77-84.
4. Clements J. Surface tension of lung extracts. Proc Soc Exp Biol Med 1957, 95:170-172.
5. Johansson J., Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 1997, 244:675-693.
6. Crewels L.A., van Golde L.M., Haagsman H.P. The pulmonary surfactant system: biochemical and clinical aspects. Lung 1997, 175:1-39.
7. Poulain F.R., Clements J.A. Pulmonary surfactant therapy. West J Med 1995, 162:43-50.
8. Leonenko Z., Gill S., Baoukina S., Monticelli L., Doehner J., Gunasekara L., et al. An elevated level of cholesterol impairs self assembly of pulmonary surfactant into a functional film. Biophys J 2007, 93:674-683.
9. Amrein M., von Nahmen A., Sieber M. A scanning force-and fluorescence light microscopy study of the structure and function of a model pulmonary surfactant. Eur Biophys J 1997, 26:349-357.
10. Gunasakara L., Schurch S., Schoel M., Kaushik N., Leonenko Z., Haufs M., et al. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim Biophys Acta 2005, 1737:27-35.
11. Johannsson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998, 1408:161-172.
12. Li D. The model of the action mechanism of Sp-C in the lung surfactant monolayers. Coll Surf 2007, 57:27-28.
13. Nakorn P., Meyer M.C., Flach C.R., Mendelsohn R., Galla H.J. Surfactant protein C and lung function: new insights into the role of alpha-helical length and palmitoylation. Eur Biophys. J 2007, 36:477-489.
14. Johannsson J. Amyloid fibrils. FEBS J 2005, 272:5941.
15. Gustaffson M. Amyloid fibril formation by pulmonary surfactant protein C. FEBS Lett 1999, 464:138-142.
16. Dobson C.W. The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 2001, 356:133-145.
17. Nelson R., Eisenberg D. Recent atomic models of amyloid fibril structure. Curr Opin Struct Bio 2006, 16:260-265.
18. Robertson E., Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006, 314:781-785.
19. Kallberg Y., Gustafsson M., Persson B., Thyberg J., Johansson J. Prediction of amyloid fibril-forming proteins. J. Biol Chem 2000, 276:12945-12950.
20. Rauk A. The chemistry of Alzheimer's disease. Chem Soc Rev 2009, 38:2698-2715.
21. Engle W.A. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008, 121:419-432.
22. Tanaka Y., Takei T., Aiba T., Masuda K., Kiuchi A., Fujiwara T. Development of synthetic lung surfactants. J Lipid Res 1986, 27:475-485.
23. Cai P., Flach C., Mendelsohn R. An infrared reflection-absorption spectroscopy study of the secondary structure in (KL4)4K, a therapeutic agent for respiratory distress syndrome, in aqueous monolayers with phospholipids. Biochemistry 2003, 42:9446-9452.
24. Nakahara H., Lee S., Sugihara G., Chang C.H., Shibata O. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfacten (Surfactant TA). Langmuir 2008, 24:3370-3379.
25. Gustafsson M., Palmblad M., Curstedt T., Johansson J., Schürch S. Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability. Biochim Biophys Acta 2000, 1466:169-178.
26. Krol S., Ross M., Sieber M., Kunneke S., Galla H.J., Janshoff A. Formation of three-dimensional protein-lipid aggregates in monolayer films induced by surfactant protein B. Biophys J 2000, 79:904-918.
27. Grigoriev D., Kragel J., Akentiev A., Noskov B., Miller R., Pison U. Relation between rheological properties and structural changes in monolayers of model lung surfactant under compression. Biophys Chem 2003, 104:633-642.
28. Fezoui Y., Hartley D., Harper J., Khurana R., Walsh D., Condron M., et al. An improved method of preparing the amyloid-β protein for fibrillogenesis and neurotoxicity experiments. Amyloid:. Int. J. Exp. Clin. Invest 2000, 7:166-178.
29. Choucair A., Chakrapani M., Chakravarthy B., Katsaras J., Johnston L.J. Preferential accumulation of Abeta(1-42) on gel phase domains of lipid bilayers: an AFM and fluorescence study. Biochim Biophys Acta 2007, 1768:146-154.
30. Pike L.J. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 2006, 47:1597-1598.
31. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
32. Pike L.J. The challenge of lipid rafts. J Lipid Res 2009, 50(Suppl):S323-S328.
33. Kim Y.H., Tero R., Takizawa U., Urisu T. Characterization of dipalmitoylphosphatidylcholine/cholesterol Langmuir-Blodgett monolayers investigated by atomic force microscopy and Fourier transform infrared spectroscopy. Jpn J Appl Phys I Reg Papers 2004, 43:3860-3864.
34. Yuan C., Johnston L.J. Phase evolution in cholesterol/DPPC monolayers: atomic force microscopy and near field scanning optical microscopy studies. J Microsc 2002, 205:136-146.
35. Murtola T., Karttunen M., Vattulainen I. Systematic coarse graining from structure using internal states: application to phospholipid/cholesterol bilayer. J Chem Phys 2009, 055101:131.
36. Finot E., Leonenko Y., Moores B., Eng L.M., Amrein M., Leonenko Z. Effect of cholesterol on electrostatics in lipid-protein films of a lung surfactant. Langmuir 2010, 26:1929-1935.
37. Hane F., Moores B., Amrein M., Leonenko Z. Effect of SP-C on surface potential distribution in pulmonary surfactant: atomic force microscopy and Kelvin-probe force microscopy study. Ultramicroscopy 2009, 109:968-973.
38. Ji S.R., Wu Y., Sui S.F. Study of β-amyloid peptide (Aβ40) insertion into phospholipid membranes using monolayer technique. Biochemistry (Mosc.). 2002, 67:1283-1288.
39. Kucerka N., Pencer J., Nieh M.P., Katsaras J. Influence of cholesterol on the bilayer properties of monounsaturated phosphatidylcholine unilamellar vesicles. Eur Phys J E 2007, 23:247-254.
40. Leonenko Z., Finot E., Vassiliev V., Amrein M. The structure and physical properties of BLES surfactant films addressed by atomic force microscopy and force measurements. Ultramicroscopy 2006, 106:687-694.